Claim being checked · Version 1 · Reviewed
“Injectable AOD-9604 has a well-characterized safety profile.”
Written and source-checked by Anthony Treviso, founder of The Peptide Field.
No dosing advice. This guide explains research. It was not independently medically reviewed, and it does not diagnose, prescribe, or recommend treatment.
Not established. The reviewed evidence does not establish this statement. This does not prove it can never be true.
Answer scope
This verdict checks the exact claim in the heading. It is not a universal grade for AOD-9604.
01 · Answer
Not established
FDA identifies limited safety data, immunogenicity concerns, and missing information for proposed injectable use.
- What kind of evidence this is
- Regulatory or product record. This answer uses an official regulator record or a specific product label.
- What this answer covers
- Compounded injectable AOD-9604. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.
- Question type
- Safety. What is known and not known about harm, warnings, and safety limits.
02 · Sources
Read the sources behind this answer
- Editorial review
- Internal editorial review recorded
- Source review
- Anthony Treviso · Founder and responsible editor
- Medical review status
- Not independently medically reviewed. Editorial source review does not replace medical review.